Medifast (MED) | Stock Overview & Key Data
Medifast Performance Comparison
Stock Range
Today's Range
Low: $13.62
High: $14.26
on August 20, 2025
52 Week Range
Low: $11.57
High: $21.98
on April 21, 2025
on December 11, 2024
All-Time High: $336.99 on May 24, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$155.5M
EPS
0.33
P/E Ratio (TTM)
42.88
Forward P/E
47.17
P/B Ratio
0.67
PEG Ratio
-0.33
Div. Yield
N/A
ROE
1.73%
Beta
0.821
Debt to Equity
6.05
Financial Highlights
Profitability
Gross Margin
72.61%
Operating Margin
-1.01%
Profit Margin
0.76%
Returns and Earnings
Return on Assets (TTM)
2.88%
Return on Equity (TTM)
1.73%
EBITDA
$14.2M
Net Income (TTM)
$3.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$43.93
Quarterly Revenue Growth (YoY)
-37.40%
Quarterly Earnings Growth (YoY)
-37.38%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Medifast MED | 155.52M Micro-cap | 7.28% | 2.61% | 1.00% | -0.98% | -18.16% | -29.18% | -89.47% | -91.51% |
| Rollins ROL | 28.08B Large-cap | 0.10% | 4.58% | 0.89% | 14.14% | 25.85% | 15.56% | 68.04% | 57.96% |
| Service SCI | 11.31B Large-cap | 1.11% | 6.05% | 4.52% | 3.54% | 5.48% | 5.54% | 27.78% | 76.61% |
| Yy Group Holding YYGH | 75.88M Micro-cap | -10.00% | -31.52% | 18.13% | 6.18% | 8.00% | 155.41% | -35.71% | -35.71% |
| Regis RGS | 47.67M Micro-cap | 0.10% | -7.81% | -9.95% | -17.44% | -18.42% | -16.05% | -36.32% | -89.34% |
| Medirom Healthcare MRM | 14.22M Micro-cap | -17.81% | 30.43% | 127.85% | 104.55% | 78.22% | -69.74% | -73.66% | -87.71% |
Ownership & Short Interest
Insider Ownership
3.20%
Institutional Ownership
80.39%
Shares Short
2M
Short Ratio
11.35
Short % of Shares Outstanding
21.41%
Average 10-Day Volume
198K
Average 90-Day Volume
211K
Medifast Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Medifast would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MED's 52-week high and low?
- In the last 52 weeks, Medifast reached a high of $21.98 (on December 11, 2024) and a low of $11.57 (on April 21, 2025).
- What is the market cap and P/E ratio for MED?
- Curious about Medifast's size and valuation? Its market capitalization stands at 155.52M. When it comes to valuation, the P/E ratio (trailing twelve months) is 42.88, and the forward P/E (looking ahead) is 47.17.
- Does MED pay dividends? If so, what's the yield?
- As for dividends, Medifast isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medifast's main competitors or similar companies to consider before investing?
When looking at Medifast, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Rollins
ROL28.08B Consumer Cyclical Personal Services 15.56% 68.04% Service
SCI11.31B Consumer Cyclical Personal Services 5.54% 27.78% Yy Group Holding
YYGH75.88M Consumer Cyclical Personal Services 155.41% -35.71% Regis
RGS47.67M Consumer Cyclical Personal Services -16.05% -36.32% Medirom Healthcare
MRM14.22M Consumer Cyclical Personal Services -69.74% -73.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medifast Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Medifast's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.73%, the Debt to Equity ratio from the most recent quarter is 6.05, and its Gross Profit Margin stands at 72.61%.
- What is the recent revenue and earnings growth for MED?
- Looking at Medifast's growth, its revenue over the trailing twelve months (TTM) was $480M. Compared to the same quarter last year (YoY), quarterly revenue grew by -37.40%, and quarterly earnings saw a YoY growth of -37.38%.
- How much of MED stock is held by insiders and institutions?
- Wondering who owns Medifast stock? Company insiders (like executives and directors) hold about 3.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 80.39%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.